etomoxir has been researched along with cerulenin in 4 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (cerulenin) | Trials (cerulenin) | Recent Studies (post-2010) (cerulenin) |
---|---|---|---|---|---|
260 | 8 | 93 | 524 | 0 | 105 |
Protein | Taxonomy | etomoxir (IC50) | cerulenin (IC50) |
---|---|---|---|
Fatty acid synthase | Homo sapiens (human) | 5.8 | |
Protease | Human immunodeficiency virus 1 | 2.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuhajda, FP; Pinn, ML; Thupari, JN | 1 |
Cheng, H; Sharp, GW; Straub, SG | 1 |
Downs, SM; Klinger, J; Mosey, JL | 1 |
Cózar-Castellano, I; Joumady, I; Perdomo, G; Sáez-Benito, A; Tirado-Vélez, JM | 1 |
4 other study(ies) available for etomoxir and cerulenin
Article | Year |
---|---|
Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Topics: Acetyl-CoA Carboxylase; Apoptosis; Breast Neoplasms; Carnitine O-Palmitoyltransferase; Cell Survival; Cerulenin; Enzyme Inhibitors; Epoxy Compounds; Fatty Acid Synthases; Fatty Acids; Female; Furans; Humans; Hypolipidemic Agents; Kinetics; Malonyl Coenzyme A; Models, Biological; Oxidation-Reduction; Tumor Cells, Cultured | 2001 |
Protein acylation in the inhibition of insulin secretion by norepinephrine, somatostatin, galanin, and PGE2.
Topics: Acylation; Acyltransferases; Animals; Cerulenin; Cyclic AMP; Dinoprostone; Enzyme Activation; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids, Unsaturated; Galanin; GTP-Binding Proteins; Hypoglycemic Agents; Insulin; Insulin Secretion; Lipid Metabolism; Male; Norepinephrine; Oxidation-Reduction; Palmitates; Palmitic Acid; Proteins; Rats; Rats, Sprague-Dawley; Somatostatin | 2003 |
Fatty acid oxidation and meiotic resumption in mouse oocytes.
Topics: 4-Butyrolactone; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Carnitine; Carnitine O-Palmitoyltransferase; Cerulenin; Cumulus Cells; Epoxy Compounds; Fatty Acids; Female; Malonyl Coenzyme A; Meiosis; Mice; Mice, Inbred C57BL; Oocytes; Oxidation-Reduction; Palmitic Acid; Ribonucleotides | 2009 |
Inhibition of fatty acid metabolism reduces human myeloma cells proliferation.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Boronic Acids; Bortezomib; Carbohydrate Metabolism; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerulenin; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; Epoxy Compounds; Fatty Acids; G1 Phase Cell Cycle Checkpoints; Glucose; Humans; Lactones; Lipid Metabolism; Multiple Myeloma; Orlistat; Oxidation-Reduction; Pyrazines; Retinoblastoma Protein | 2012 |